July 15, 2021 - dabl Clinical Trials

New Hypertension Core Lab partnership
15 Jul 2021

Hypertension affects a substantial part of the world’s population. Treatment options include lifestyle changes and drug-based therapies. Device-based therapies for hypertension are under development and used within the context of clinical studies and randomized controlled and sham-controlled trials. Research on device-based therapies for hypertension typically use ambulatory blood pressure monitoring (ABPM) as primary endpoint. Key […]

{...} click to continue